Ildong stock enters skincare market through IDNINE joint venture

Ildong Pharmaceutical Group is expanding into functional skincare through a new joint venture with Nine Company. The company announced the venture on October 27, 2026, after a launch ceremony held in Seoul on October 26, according to MoneyToday.

IDNINE targets dermocosmetics

The venture, named IDNINE, will combine Ildong's probiotics and microbiome research with Nine Company's brand planning and marketing capabilities. Its primary focus is dermocosmetics, a category that applies skin science to functional cosmetic products.

The planned products will use Cera-Glow, a microbiome-based probiotic cosmetic ingredient developed with Ildong's proprietary technology. MoneyToday reported that the ingredient is associated with ceramide production, while IDNINE plans to develop products focused on skin-barrier management and introduce a high-functionality skincare line from 2027.

Technology meets consumer branding

Ildong has researched skincare applications based on active metabolites produced during the fermentation of probiotic strains. The report said the group holds two patents related to Cera-Glow and has published two papers in SCI-level journals. These points support the venture's stated effort to combine technical development with a consumer-facing brand strategy, but they do not establish commercial success.

For investors, the joint venture adds a new commercialization route beyond Ildong's established pharmaceutical and healthcare activities. The opportunity remains dependent on product development, market acceptance and the ability of the partners to translate research capabilities into recurring sales.

For a broader view, the current market reports provide context on international trading conditions, including the South Korean market.

Further company-specific coverage is available in more news and analyses on Ildong stock.